Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells

Nature Biotechnology

Volumn 33, Issue 9, 2015, Pages 970-979

  Birket, Matthew J ^a   Ribeiro, Marcelo C ^a   Verkerk, Arie O ^b   Ward, Dorien ^a   Leitoguinho, Ana Rita ^a   Den Hartogh, Sabine C ^a   Orlova, Valeria V ^a   Devalla, Harsha D ^a   Schwach, Verena ^a   Bellin, Milena ^a   Passier, Robert ^a   Mummery, Christine L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; EXPANSION; FINANCIAL MARKETS; HEART; STEM CELLS; TISSUE ENGINEERING;

CARDIAC DISEASE; CARDIOMYOCYTES; HEART DEVELOPMENT; INSULIN-LIKE GROWTH FACTOR-1; MOLECULAR BASIS; PLURIPOTENT STEM CELLS; PROGENITOR CELL; RENEWABLE SOURCES;

CELLS;

MORPHOGEN; MYC PROTEIN; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN;

ANIMAL CELL; ARTICLE; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL FATE; CELL LINEAGE; CELL POPULATION; CELL RENEWAL; CLONOGENESIS; CONTROLLED STUDY; EMBRYO; HEART DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; TISSUE ENGINEERING; BATCH CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY; PROCEDURES;

BATCH CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HEDGEHOG PROTEINS; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84941072102     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3271     Document Type: Article

References (57)

1. Drawnel, F.M. et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Reports 9, 810-820 (2014).
2. Matsa, E., Burridge, P.W., Wu, J.C. Human stem cells for modeling heart disease and for drug discovery. Sci. Transl. Med. 6, 239ps6 (2014).
3. Lundy, S.D., Gantz, J.A., Pagan, C.M., Filice, D., Laflamme, M.A. Pluripotent stem cell derived cardiomyocytes for cardiac repair. Curr. Treat. Options Cardiovasc. Med. 16, 319 (2014).
4. Bhave, M., Akhter, N., Rosen, S.T. Cardiovascular toxicity of biologic agents for cancer therapy. Oncology 28, 482-490 (2014).
5. Birket, M.J., Mummery, C.L. Pluripotent stem cell derived cardiovascular progenitors-a developmental perspective. Dev. Biol. 400, 169-179 (2015).
6. Vincent, S.D., Buckingham, M.E. How to make a heart: the origin and regulation of cardiac progenitor cells. Curr. Top. Dev. Biol. 90, 1-41 (2010).
7. Cai, C.-L. et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5, 877-889 (2003).
8. Lints, T.J., Parsons, L.M., Hartley, L., Lyons, I., Harvey, R.P. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119, 419-431 (1993).
9. Ma, Q., Zhou, B., Pu, W.T. Reassessment of Isl1 and Nkx2-5 cardiac fate maps using a Gata4-based reporter of Cre activity. Dev. Biol. 323, 98-104 (2008).
10. Laugwitz, K.-L. et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653 (2005).
11. Moretti, A. et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151-1165 (2006).
12. Wu, S.M. et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137-1150 (2006).
13. Mommersteeg, M.T.M. et al. Molecular pathway for the localized formation of the sinoatrial node. Circ. Res. 100, 354-362 (2007).
14. Wiese, C. et al. Circ. Res. 104, 388-397 (2009).
15. Liang, X. et al. HCN4 dynamically marks the first heart field and conduction system precursors. Circ. Res. 113, 399-407 (2013).
16. Später, D. et al. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat. Cell Biol. 15, 1098-1106 (2013).
17. Kattman, S.J. et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240 (2011).
18. Wierstra, I., Alves, J. The c-myc promoter: still mysterY and challenge. Adv. Cancer Res. 99, 113-333 (2008).
19. Gittenberger-De Groot, A.C. et al. Nkx2.5 negative myocardium of the posterior heart field and its correlation with podoplanin expression in cells from the developing cardiac pacemaking and conduction system. Anat. Rec. 290, 115-122 (2007).
20. Dyer, L.A. et al. BMP signaling modulates hedgehog-induced secondary heart field proliferation. Dev. Biol. 348, 167-176 (2010).
21. Gude, N. et al. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ. Res. 99, 381-388 (2006).
22. Keren-Politansky, A., Keren, A., Bengal, E. Neural ectoderm-secreted FGF initiates the expression of Nkx2.5 in cardiac progenitors via a p38 MAPK/CREB pathway. Dev. Biol. 335, 374-384 (2009).
23. Liberatore, C.M., Searcy-Schrick, R.D., Vincent, E.B., Yutzey, K.E. Nkx-2.5 gene induction in mice is mediated by a Smad consensus regulatory region. Dev. Biol. 244, 243-256 (2002).
24. Reifers, F., Walsh, E.C., Leger, S., Stainier, D.Y., Brand, M. Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development 127, 225-235 (2000).
25. Schultheiss, T.M., Burch, J.B., Lassar, A.B. A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev. 11, 451-462 (1997).
26. Barron, M., Gao, M., Lough, J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev. Dyn. 218, 383-393 (2000).
27. Inman, G.J. et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-? superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74 (2002).
28. Den Hartogh, S.C. et al. Dual reporter MESP1mCherry/w-NKX2-5eGFP/w hESCs enable studying early human cardiac differentiation. Stem Cells 33, 56-67 (2015).
29. Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524-528 (2008).
30. Ardehali, R. et al. Prospective isolation of human embryonic stem cell-derived cardiovascular progenitors that integrate into human fetal heart tissue. Proc. Natl. Acad. Sci. USA 110, 3405-3410 (2013).
31. van Berlo, J.H. et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014).
32. James, D. et al. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGF? inhibition is Id1 dependent. Nat. Biotechnol. 28, 161-166 (2010).
33. Marques, S.R., Lee, Y., Poss, K.D., Yelon, D. Reiterative roles for FGF signaling in the establishment of size and proportion of the zebrafish heart. Dev. Biol. 321, 397-406 (2008).
34. de Pater, E. et al. Bmp signaling exerts opposite effects on cardiac differentiation. Circ. Res. 110, 578-587 (2012).
35. Ueno, S. et al. Biphasic role for Wnt/?-catenin signaling in cardiac specification in zebrafish and embryonic stem cells. Proc. Natl. Acad. Sci. USA 104, 9685-9690 (2007).
36. Goumans, M.-J. et al. TGF-?1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res. 1, 138-149 (2007).
37. Verkerk, A.O., van Ginneken, A.C.G., Wilders, R. Pacemaker activity of the human sinoatrial node: role of the hyperpolarization-activated current, I(f). Int. J. Cardiol. 132, 318-336 (2009).
38. Xi, J. et al. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. FASEB J. 24, 2739-2751 (2010).
39. Jackson, T. et al. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol. Cell. Biol. 10, 3709-3716 (1990).
40. Noseda, M., Peterkin, T., Simões, F.C., Patient, R., Schneider, M.D. Cardiopoietic factors extracellular signals for cardiac lineage commitment. Circ. Res. 108, 129-152 (2011).
41. Cai, W. et al. Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment. Genes Dev. 27, 2332-2344 (2013).
42. Waldo, K.L. et al. Conotruncal myocardium arises from a secondary heart field. Development 128, 3179-3188 (2001).
43. Milgrom-Hoffman, M. et al. The heart endocardium is derived from vascular endothelial progenitors. Development 138, 4777-4787 (2011).
44. Zhang, Q. et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 21, 579-587 (2011).
45. Devalla, H.D. et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol. Med. 7, 394-410 (2015).
46. Kattman, S.J., Huber, T.L., Keller, G.M. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723-732 (2006).
47. Qyang, Y. et al. The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a WNT/?-catenin pathway. Cell Stem Cell 1, 165-179 (2007).
48. Bu, L. et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460, 113-117 (2009).
49. Domian, I.J. et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 326, 426-429 (2009).
50. Moretti, A. et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 24, 700-711 (2010).
51. Elliott, D.A. et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8, 1037-1040 (2011).
52. Miano, J.M., Cserjesi, P., Ligon, K.L., Periasamy, M., Olson, E.N. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ. Res. 75, 803-812 (1994).
53. Bellin, M. et al. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. EMBO J. 32, 3161-3175 (2013).
54. Maherali, N. et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340-345 (2008).
55. Birket, M.J. et al. PGC-1-? and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Rep. 1, 560-574 (2013).
56. Hao, J. et al. In vivo structure activity relationship study of dorsomorphin analogs identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 5, 245-253 (2010).
57. Rape, A.D., Guo, W.-H., Wang, Y.-L. The regulation of traction force in relation to cell shape and focal adhesions. Biomaterials 32, 2043-2051 (2011).